Trial intelligence / Profile preview

Topical Hyaluronic Acid for Palatal Wound Healing

NCT02534415Phase 4

Key facts

Status
Completed
Start
Aug 2013
Primary completion
Jul 2015
Sponsor
Marmara University
Modality
Hydrogel Systems
Drugs
hyaluronic acid sodium composite gel for injection
Conditions
surgical wound
01

Overview

Phase 4, randomised, single-blind trial of hyaluronic acid sodium composite gel for injection in surgical wound (3 arms), sponsored by Marmara University. Primary endpoints: Pain at 21 days and Burning Sensation at 21 days. Started Aug 2013; status: completed.

02

Design

3 arms
Study design
RandomizedSingle-blind
  • Periodontal dressing

    Standard of care dressing applied at baseline and day 3

  • 0.2% Hyaluronic acid

    0.2% HA gel applied under dressing at baseline and day 3

  • 0.8% Hyaluronic acid

    0.8% HA gel applied under dressing at baseline and day 3

03

Endpoints

Primary

  • Pain

  • Burning Sensation

Secondary

  • Color match

  • Consistency

  • Epithelialization

Beyond the preview

Go deeper on NCT02534415.

Full results, competitive context and analysis are in the Gosset platform.

Full results & analysis

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02534415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call